EGFR and neoplasm: The cell growth-signaling proteins, such as AKT and ERK activation (phosphorylation form), were dramatically inhibited in EGFR gene-edited SW579 cells; such result also induced the expression of tumor-suppressive proteins, such as P53 and P21.